Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00968721 · ClinicalTrials.gov registry record
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
A clinical trial, sponsored by Vanderbilt University.
- Terminated
- Registry status
- 55
- Enrollment target
NCT00968721 is a clinical trial that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 55 participants.
The verdict
NCT00968721 was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The primary purpose of this study is to pilot test an instrument that the investigators will develop to assess decision influences on inflammatory bowel disease patients' medication adherence decision-making. This pilot study will use an exploratory, descriptive cross-sectional survey approach to pilot test the instrument and answer the research questions. The main hypothesis is that patients at risk for intentionally modifying their prescribed medication regimen will differ on influences on decision-making, health status, and utilization of the IBD clinic services compared to those who are intentionally adherent and who continue adherence over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00968721
The ClinicalTrials.gov registry entry for NCT00968721 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00968721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00968721 about?
NCT00968721 is a clinical study titled "Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use". The primary purpose of this study is to pilot test an instrument that the investigators will develop to assess decision influences on inflammatory bowel disease patients' medication adherence decision-making. This pilot study will use an exploratory, descriptive cross-sectional survey approach to p...
What is the current status of trial NCT00968721?
This trial is currently terminated. The enrollment target is 55 participants. The study started on 2010-06. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT00968721?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.